Rebranding efforts include a new logo, overall brand presence, and corporate design.
Piper Sandler analyst David Amsellem reiterated a Buy rating on Corcept Therapeutics (CORT – Research Report) today and set a price target of ...
TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the “Investors” page on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback